XCL1 and breast carcinoma: Collectively, our results demonstrate that the XCL1–XCR1 axis promotes MDA-MB-231 and SK-BR-3 breast cancer cell migration via activation of the ERK/HIF-1α/EMT signaling pathway (Figure 9).